Upgrade to SI Premium - Free Trial

Amphastar Pharmaceuticals (AMPH) PT Raised to $21 at BMO Capital

November 9, 2018 9:02 AM
BMO Capital analyst Gary Nachman raised the price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $21.00 (from $19.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change

Next Articles